Aquestive Therapeutics 주식 가격. AQST - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

가격

3.10

매수가

3.05

매도가

3.35

거래량

0.00 일간 변동폭 0.00

2.24 52주 범위 6.23

market_cap

282.652M

전일 종가

3.10

개장가

최근 거래 시간

3.1

마지막 거래 시간

18:12:10

재정 규모

VWAP

평균 볼륨(3m)

1,606,250

발행 주식

91,178,193

배당수익률

주가수익률

-35.92

주당순이익(EPS)

-0.09

매출

50.58M

순이익

-7.87M

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier stage pipeline for the t... Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States. 더 보기

섹터

Pharmaceutical Preparations

산업

Pharmaceutical Preparations

웹사이트

www.aquestive.com

본부

Wilmington, Delaware, USA

설립됨

Aquestive Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker AQST. The last closing price for Aquestive Therapeutics was US$3.10. Over the last year, Aquestive Therapeutics shares have traded in a share price range of US$ 2.24 to US$ 6.23.

Aquestive Therapeutics currently has 91,178,193 shares in issue. The market capitalisation of Aquestive Therapeutics is US$282.65 million. Aquestive Therapeutics has a price to earnings ratio (PE ratio) of -35.92.

Form 8-K - Current report

Aquestive Therapeutics Provides Business Update and Outlines Key 2025 Objectives

On track to submit Anaphylm™ (epinephrine) Sublingual Film NDA in Q1 2025Actively recruiting subjects in the Anaphylm pediatric clinical trialSuccessfully completed AQST-108 (epinephrine) Topical...

Form 8-K - Current report

Aquestive Therapeutics Receives U.S. FDA Orphan Drug Exclusivity for Libervant® (diazepam) Buccal Film in Pediatric Patients with Seizure Clusters Ages Two to Five

WARREN, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful...

Form 8-K - Current report

Aquestive Therapeutics Announces Positive FDA Feedback and Reaffirms NDA Submission Guidance for Anaphylm™ (epinephrine) Sublingual Film

Reaffirms New Drug Application (NDA) first quarter 2025 submission guidanceConfirms no additional adult clinical trials are necessary prior to NDA submission Commenced pediatric trial in the U.S...

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	-0.04	-1.27388535032	3.14	3.3	3.01	1350769	3.11523596	CS
4	-0.51	-14.1274238227	3.61	3.79	2.96	1522544	3.29509211	CS
12	-2.4	-43.6363636364	5.5	5.8	2.96	1606250	4.20050923	CS
26	-0.12	-3.72670807453	3.22	5.8	2.96	1436264	4.31315649	CS
52	0.64	26.0162601626	2.46	6.23	2.24	1709983	4.02313586	CS
156	-0.12	-3.72670807453	3.22	6.23	0.618	898235	3.10546433	CS
260	-1.05	-25.3012048193	4.15	9.465	0.618	845757	3.86811864	CS

AQST - Frequently Asked Questions (FAQ)

What is the current Aquestive Therapeutics share price?

The current share price of Aquestive Therapeutics is US$ 3.10

How many Aquestive Therapeutics shares are in issue?

Aquestive Therapeutics has 91,178,193 shares in issue

What is the market cap of Aquestive Therapeutics?

The market capitalisation of Aquestive Therapeutics is USD 282.65M

What is the 1 year trading range for Aquestive Therapeutics share price?

Aquestive Therapeutics has traded in the range of US$ 2.24 to US$ 6.23 during the past year

What is the PE ratio of Aquestive Therapeutics?

The price to earnings ratio of Aquestive Therapeutics is -35.92

What is the cash to sales ratio of Aquestive Therapeutics?

The cash to sales ratio of Aquestive Therapeutics is 5.59

What is the reporting currency for Aquestive Therapeutics?

Aquestive Therapeutics reports financial results in USD

What is the latest annual turnover for Aquestive Therapeutics?

The latest annual turnover of Aquestive Therapeutics is USD 50.58M

What is the latest annual profit for Aquestive Therapeutics?

The latest annual profit of Aquestive Therapeutics is USD -7.87M

What is the registered address of Aquestive Therapeutics?

The registered address for Aquestive Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Aquestive Therapeutics website address?

The website address for Aquestive Therapeutics is www.aquestive.com

Which industry sector does Aquestive Therapeutics operate in?

Aquestive Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

가장 활성
% 상승자
% 패자

기호	가격	볼륨
DWTXDogwood Therapeutics Inc	US$ 2.98 (59.36%)	1.48M
BBGIBeasley Broadcast Group Inc	US$ 13.17 (59.25%)	19
QETAQuetta Acquisition Corporation	US$ 16.82 (59.13%)	5
IROHIron Horse Acquisition Corporation	US$ 16.01 (54.99%)	4
CRKNCrown Electrokinetics Corporation	US$ 0.1727 (38.16%)	35.66M
GOEVCanoo Inc	US$ 0.3697 (-72.61%)	861.16k
ELVNEnliven Therapeutics Inc	US$ 10.11 (-52.91%)	14
CUBLionheart Holdings	US$ 5.11 (-49.51%)	1
ALRSAlerus Financial Corporation	US$ 12.01 (-38.79%)	3
MDXGMiMedx Group Inc	US$ 6.01 (-34.10%)	8
CRKNCrown Electrokinetics Corporation	US$ 0.1727 (38.16%)	35.66M
CGBSCrown LNG Holdings Ltd	US$ 0.9522 (27.33%)	6.66M
RIMEAlgorhythm Holdings Inc	US$ 0.0396 (-4.81%)	4.36M
SHViShares Short Treasury Bond ETF	US$ 110.36 (0.02%)	3.97M
ACONAclarion Inc	US$ 0.0474 (12.06%)	2.56M